| Stage | ORN | % of rev | GHM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $256M | 100.00% | $71M | 100.00% | ORN ×3.59 |
| Gross profit | $33M | 12.94% | $18M | 24.95% | GHM +12.0pp |
| Operating income | $9M | 3.33% | $4M | 5.82% | GHM +2.5pp |
| Pre-tax income | $6M | 2.29% | $4M | 5.86% | GHM +3.6pp |
| Net income | $5M | 2.14% | $4M | 5.48% | GHM +3.3pp |
| Stage | ORN | GHM | Gap · A − B |
|---|---|---|---|
| Revenue | $256M100.00% | $71M100.00% | ORN ×3.59 |
| Gross profit | 12.94%$33M | 24.95%$18M | GHM +12.0pp |
| Operating income | 3.33%$9M | 5.82%$4M | GHM +2.5pp |
| Pre-tax income | 2.29%$6M | 5.86%$4M | GHM +3.6pp |
| Net income |
| 2.14%$5M |
| 5.48%$4M |
| GHM +3.3pp |
No disclosed counterparties: GHM.
None